Could essential oils tame chemo nausea? a new trial puts aromatherapy to the test

NCT ID NCT07761325

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This phase III trial is testing whether adding aromatherapy—using lemon, lavender, and peppermint essential oils—to standard anti-nausea medication can better prevent nausea and vomiting in breast cancer patients receiving highly emetogenic chemotherapy. About 374 patients will be randomly assigned to receive either standard antiemetic therapy alone or standard therapy plus aromatherapy. The study will measure how many patients have no vomiting and need no rescue medication during the first five days after chemotherapy, along with quality of life and other outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Aromatherapy with lemon, lavender, and peppermint essential oils delivered via an ultrasonic diffuser, combined with standard antiemetic drugs.
What this could lead to
If effective, aromatherapy could become a simple, drug-free add-on to reduce nausea and vomiting for breast cancer patients undergoing chemotherapy, improving their quality of life.
What could go wrong
The trial is still testing the idea, and results may not show a clear benefit. Aromatherapy might not work for everyone, and any effect could be small or due to placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AROMATHERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.